Delivery Order W81K0225DA013-W81K0225FA137
Award Date 10/1/25
Potential Completion Date 9/30/30
Potential Value $298K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Joint Base Lewis-McChord, WA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a delivery order to Roche Diagnostics Corporation on October 1, 2025, for Roche Ventana Medical System platforms, including reagents and instruments, with a ceiling value of $354,964.92. The order is a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by September 30, 2026. The work will be performed in Castleton, Indiana. This delivery order represents a child contract under a larger vehicle, enabling the Defense...
- This federal contract award is for $205,240.00 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is a firm fixed-price purchase order awarded by the Defense Health Agency, a defense agency under the Department of Defense, to provide automated immunohistochemistry (IHC) slide staining platforms, antibody stains, reagents, and supplies to support the Anatomic Pathology mission at Madigan Army...
- This is a firm-fixed-price purchase order awarded by the Defense Health Agency to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, valued at $1,008,529.39, is for a cost-per-stain lease of an immunohistochemistry (IHC) staining platform to support the Department of Pathology at Madigan Army Medical Center in Tacoma, Washington. This is a new 5-year contract, with a base period...
- This is a firm-fixed-price delivery order contract awarded by the Defense Health Agency to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $712,750 contract is for immunohistochemical testing services with a performance period through September 30, 2024. Roche Diagnostics has previously received numerous federal contract awards, including through Indefinite Delivery Contracts and Blanket Purchase Agreements, to provide medical...
- This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $712,750.00, was awarded by the Defense Health Agency (DHA) for "IHC COST PER TEST" services. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract vehicle, likely a Blanket Purchase Agreement (BPA) or Indefinite...
- The Defense Health Agency awarded a $2.21M delivery order to Roche Diagnostics Corporation for chemistry and immunoassay testing services, effective October 1, 2025, with completion targeted for September 30, 2026. This firm fixed-price contract represents a child order under a larger vehicle and carries no set-aside designation, allowing Roche to compete openly in the federal marketplace. The work will be performed at Fort Sam Houston in San Antonio, Texas, a major military medical facility....
- This federal contract award was issued by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $178,187.52 Firm Fixed Price delivery order contract provides immunohistochemistry (IHC) assays, slide stainers, cytology/histology reagents, and other consumables in support of the Naval Medical Center in Portsmouth, Virginia. The contract...
- The U.S. government awarded Roche Diagnostics Corporation a firm fixed-price purchase order valued at $254,791.40 for an automated immunohistochemistry (IHC) system to be delivered to Ames, Iowa. The contract, awarded on August 26, 2024, with a completion deadline of October 20, 2029, was issued without a set-aside designation through a civilian federal agency's Midwest Area office. Roche Diagnostics Corporation, a foreign-owned manufacturer specializing in in vitro diagnostics, laboratory...
- This is a delivery order contract awarded by the Defense Health Agency to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $178,187.52, is for the provision of immunohistochemistry (IHC) cost per test, slide stainer, cytology/histology reagents, and consumables in support of the Naval Medical Center in Portsmouth, Virginia. The contract does not...
- The Defense Health Agency awarded a $1.74M delivery order to Roche Diagnostics Corporation for a fully automated sample preparation and consultation system to support the Department of Pathology and Area Laboratory Services histology laboratory at Brooke Army Medical Center (BAMC) in Fort Sam Houston, Texas. The firm fixed-price contract, which carries no set-aside designation, is scheduled for completion by September 30, 2028, and represents a continuation of Roche's established role as a...